161 related articles for article (PubMed ID: 30223241)
1. A circular toxicity approach to isoprostanes: From markers of oxidative stress, to epidemiological warning systems and agents of aquatic toxicity.
Pais RT; Sousa ACA; Pastorinho MR
Environ Pollut; 2018 Dec; 243(Pt A):654-660. PubMed ID: 30223241
[TBL] [Abstract][Full Text] [Related]
2. New techniques to detect oxidative stress markers: mass spectrometry-based methods to detect isoprostanes as the gold standard for oxidative stress in vivo.
Yin H
Biofactors; 2008; 34(2):109-24. PubMed ID: 19706977
[TBL] [Abstract][Full Text] [Related]
3. Insights into oxidative stress: the isoprostanes.
Montuschi P; Barnes P; Roberts LJ
Curr Med Chem; 2007; 14(6):703-17. PubMed ID: 17346157
[TBL] [Abstract][Full Text] [Related]
4. Cyclopentenone isoprostanes are novel bioactive products of lipid oxidation which enhance neurodegeneration.
Musiek ES; Breeding RS; Milne GL; Zanoni G; Morrow JD; McLaughlin B
J Neurochem; 2006 Jun; 97(5):1301-13. PubMed ID: 16638022
[TBL] [Abstract][Full Text] [Related]
5. A case of contagious toxicity? Isoprostanes as potential emerging contaminants of concern.
Gaw S; Glover CN
Sci Total Environ; 2016 Aug; 560-561():295-8. PubMed ID: 27102276
[TBL] [Abstract][Full Text] [Related]
6. Measurement of isoprostanes as markers of oxidative stress in neuronal tissue.
Milatovic D; Aschner M
Curr Protoc Toxicol; 2009 Feb; Chapter 12(Supplement 39):Unit12.14. PubMed ID: 20191108
[TBL] [Abstract][Full Text] [Related]
7. Isoprostanes-biomarkers of lipid peroxidation: their utility in evaluating oxidative stress and analysis.
Janicka M; Kot-Wasik A; Kot J; Namieśnik J
Int J Mol Sci; 2010 Nov; 11(11):4631-59. PubMed ID: 21151461
[TBL] [Abstract][Full Text] [Related]
8. The isoprostanes: unique bioactive products of lipid peroxidation.
Morrow JD; Roberts LJ
Prog Lipid Res; 1997 Mar; 36(1):1-21. PubMed ID: 9373618
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the biochemistry and clinical relevance of the isoprostane pathway.
Musiek ES; Yin H; Milne GL; Morrow JD
Lipids; 2005 Oct; 40(10):987-94. PubMed ID: 16382569
[TBL] [Abstract][Full Text] [Related]
10. F2-isoprostanes are not just markers of oxidative stress.
Comporti M; Signorini C; Arezzini B; Vecchio D; Monaco B; Gardi C
Free Radic Biol Med; 2008 Feb; 44(3):247-56. PubMed ID: 17997380
[TBL] [Abstract][Full Text] [Related]
11. The isoprostanes--25 years later.
Milne GL; Dai Q; Roberts LJ
Biochim Biophys Acta; 2015 Apr; 1851(4):433-45. PubMed ID: 25449649
[TBL] [Abstract][Full Text] [Related]
12. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo.
Roberts LJ; Morrow JD
Free Radic Biol Med; 2000 Feb; 28(4):505-13. PubMed ID: 10719231
[TBL] [Abstract][Full Text] [Related]
13. Electrophilic cyclopentenone isoprostanes in neurodegeneration.
Musiek ES; McLaughlin B; Morrow JD
J Mol Neurosci; 2007 Sep; 33(1):80-6. PubMed ID: 17901550
[TBL] [Abstract][Full Text] [Related]
14. Lipid peroxidation products as oxidative stress biomarkers.
Niki E
Biofactors; 2008; 34(2):171-80. PubMed ID: 19706982
[TBL] [Abstract][Full Text] [Related]
15. Quantification of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress.
Milne GL; Yin H; Brooks JD; Sanchez S; Jackson Roberts L; Morrow JD
Methods Enzymol; 2007; 433():113-26. PubMed ID: 17954231
[TBL] [Abstract][Full Text] [Related]
16. Plasma and urinary F
Granick M; Leuin AS; Trepanier LA
J Feline Med Surg; 2021 Aug; 23(8):692-699. PubMed ID: 33146574
[TBL] [Abstract][Full Text] [Related]
17. Are isoprostanes a clinical marker for antioxidant drug investigation?
Souvignet C; Cracowski JL; Stanke-Labesque F; Bessard G
Fundam Clin Pharmacol; 2000; 14(1):1-10. PubMed ID: 10681068
[TBL] [Abstract][Full Text] [Related]
18. Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress.
Morrow JD; Roberts LJ
Methods Enzymol; 1999; 300():3-12. PubMed ID: 9919502
[TBL] [Abstract][Full Text] [Related]
19. Today's oxidative stress markers.
Czerska M; Mikołajewska K; Zieliński M; Gromadzińska J; Wąsowicz W
Med Pr; 2015; 66(3):393-405. PubMed ID: 26325052
[TBL] [Abstract][Full Text] [Related]
20. Unresolved issues in the analysis of F2-isoprostanes, F4-neuroprostanes, isofurans, neurofurans, and F2-dihomo-isoprostanes in body fluids and tissue using gas chromatography/negative-ion chemical-ionization mass spectrometry.
Yen HC; Wei HJ; Lin CL
Free Radic Res; 2015; 49(7):861-80. PubMed ID: 25812589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
